Jan 22, 2026

Ubisoft (UBI) Stock: Restructuring Efforts and Game Cancellations Prompt 33% Dip

TLDR Ubisoft’s stock dropped 33% following organizational changes and the cancellation of six games. The company plans to shut dow...

Jan 22, 2026

Galaxy Digital Raises $100 Million for New Crypto Hedge Fund

TLDR Mike Novogratz’s Galaxy Digital raises $100 million for new hedge fund launching in Q1 2026 Fund will allocate 30% to direct...

Jan 22, 2026

Daily Market Update: Crypto and Stocks Whipsaw as Trump Backs Off Tariff Threats

TLDR Bitcoin dropped to $87,300 before bouncing back toward $90,000 after Trump withdrew tariff threats against European countries...

Jan 21, 2026

Bitcoin and Stocks Rebound as Trump Halts Greenland Tariffs Threats

TLDR Bitcoin surged back to $90,000 after President Trump announced he would not impose tariffs on European countries over Greenla...

Jan 21, 2026

Cathie Wood’s ARK Invest Buys Broadcom, BYD, and WeRide Stock on January 20

TLDR ARK Invest purchased $10.8 million in Broadcom shares on January 20 following a 5.4% stock decline Wood added $2.53 million i...

Jan 21, 2026

Rigetti Computing (RGTI) Stock: $8.4M Quantum Order Has Analysts Raising Targets

TLDR Rigetti Computing received an $8.4 million order for a 108-qubit quantum computer, showing growing demand for on-premises qua...

Jan 21, 2026

Oklo Stock: Bank of America Upgrades to Buy After Meta Deal

TLDR Bank of America upgraded Oklo (OKLO) stock to Buy from Neutral, raising the price target from $111 to $127 Oklo signed a bind...

Jan 21, 2026

Johnson & Johnson (JNJ) Stock Drops Despite Earnings Beat and Strong 2026 Outloo...

TLDR Johnson & Johnson beat Q4 estimates with adjusted earnings of $2.46 per share versus $2.42 expected and sales of $24.56 billi...

Jan 21, 2026

Block (XYZ) Stock: Company Crosses $200 Billion in Total Lending Volume

TLDR Block hit $200 billion in total loans across Cash App Borrow, Afterpay, and Square Loans since launch Proprietary underwritin...

Jan 21, 2026

Rapt Therapeutics (RAPT) Stock: Pharma Giant GSK Pays $2.2 Billion for Biotech

TLDR GSK is buying Rapt Therapeutics for $58 per share in cash, valuing the deal at $2.2 billion RAPT stock climbed 65.76% over th...